Korea S.E.
23:00:00 16/05/2024 BST
5-day change
1st Jan Change
27,000
KRW
-1.82%
-3.05%
+6.51%
InBody Co., Ltd.'s Equity Buyback announced on February 28, 2017 has closed with 130,000 shares, representing 0.96% for KRW 2,848.8 million.
The company closed its plan on March 29, 2017.
InBody Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
15/05/23
CI
InBody Releases BPBIO 220 and BPBIO 250
29/06/22
CI
Inbody Co.,Ltd Releases New Bwa 2.0 Body Water Analyzer
01/04/22
CI
Orangetheory® Fitness Partnership with Inbody to Provide Members Body Composition and Heart Rate Analytics
11/01/22
CI
Tranche Update on InBody Co., Ltd.'s Equity Buyback Plan announced on March 13, 2020.
17/09/20
CI
Tranche Update on InBody Co., Ltd.'s Equity Buyback Plan announced on March 13, 2020.
17/09/20
CI
InBody Co., Ltd.'s Equity Buyback announced on March 13, 2020, has expired with 274,995 shares, representing 2.07% for KRW 4,986.97.
13/09/20
CI
Tranche Update on InBody Co., Ltd.'s Equity Buyback Plan announced on March 13, 2020.
15/06/20
CI
InBody Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
13/03/20
CI
InBody Co., Ltd. authorizes a Buyback Plan.
12/03/20
CI
InBody Partners with Orangetheory® Fitness to Advance Technology Offerings with Body Composition Analysis
16/01/20
CI
InBody to Introduce the InBody 970 Device at CES
03/01/20
CI
InBody Releases Consumer Smart Scale Device
14/06/19
CI
Tranche Update on InBody Co., Ltd.'s Equity Buyback Plan announced on December 21, 2018.
25/03/19
CI
InBody Co., Ltd. announces an Equity Buyback for KRW 4,000 million worth of its shares.
20/12/18
CI
InBody Co., Ltd. authorizes a Buyback Plan.
20/12/18
CI
Tranche Update on InBody Co., Ltd.'s Equity Buyback Plan announced on February 28, 2017.
03/04/17
CI
InBody Co., Ltd.'s Equity Buyback announced on February 28, 2017 has closed with 130,000 shares, representing 0.96% for KRW 2,848.8 million.
28/03/17
CI
InBody Co., Ltd. announces an Equity Buyback for 130,000 shares.
28/02/17
CI
InBody Co., Ltd. authorizes a Buyback Plan.
27/02/17
CI
InBody Co., Ltd.(KOSDAQ:A041830) added to Russell Global Index
29/06/15
CI
Wasatch Advisors Inc. and others acquired 5.01% stake in Biospace Co., Ltd..
11/06/15
CI
Korea Securities Finance Corporation, Investment Arm acquired 4.19% stake in Biospace Co., Ltd..
10/04/14
CI
Biospace Co., Ltd. Proposes Cash Dividend
17/02/13
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
InBody Co., Ltd., formerly Biospace Co., Ltd., is a Korea-based company engaged in the manufacture of electronic medical devices. The Company mainly produces body composition analyzers under the brand names of InBody and LookinâBody. The Company mainly produces body composition analyzers under the brand name InBody and LookinâBody. Its InBody series products include InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10 and InBody J10. Its Lookin' series products include LookinâBody3.0 and LookinâBody Basic, which are used for measuring proteins, minerals, fats, moistures and others. It also provides body mass index (BMI) measuring devices under the brand name of BSM. The Company distributes its products within domestic market and to overseas markets.
More about the company
Last Close Price
27,000
KRW
Average target price
38,000
KRW
Spread / Average Target
+40.74%
Consensus
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
INBODY CO.,LTD 
